This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Published 16 December 2021 Last updated 22 December 2022 +show all updates
28 products have been added to the list: Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials;Normal immunoglobulin human 5g/50ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 2.5ml vials;Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials;Normal immunoglobulin human 30g/300ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 15ml vials;Naloxone 1.8mg/0.1ml nasal spray unit dose;Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free;Interferon beta-1b 300microgram powder and solvent for solution for injection vials;Saxagliptin 2.5mg / Metformin 1g tablets;Saxagliptin 5mg / Dapagliflozin 10mg tablets;Eptacog alfa (activated) 1mg (50,000unit) powder and solvent for solution for injection pre-filled syringes;Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection pre-filled syringes;Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection pre-filled syringes;Eptacog alfa (activated) 8mg (400,000unit) powder and solvent for solution for injection pre-filled syringes;Turoctocog alfa pegol 1,000unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 1,500unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 2,000unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 500unit powder and solvent for solution for injection vials;Turoctocog alfa 250unit powder and solvent for solution for injection vials;Turoctocog alfa 500unit powder and solvent for solution for injection vials;Turoctocog alfa 1,000unit powder and solvent for solution for injection vials;Turoctocog alfa 1,500unit powder and solvent for solution for injection vials;Turoctocog alfa 2,000unit powder and solvent for solution for injection vials;Turoctocog alfa 3,000unit powder and solvent for solution for injection vials;Catridecacog 2,500unit powder and solvent for solution for injection vials;Nonacog beta pegol 1,000unit powder and solvent for solution for injection vials;Nonacog beta pegol 2,000unit powder and solvent for solution for injection vials;Nonacog beta pegol 500unit powder and solvent for solution for injection vials
Added 2 products to the list: Omalizumab 75mg/0.5ml solution for injection pre-filled syringes and Oxybutynin 3.9mg/24 hours transdermal patches.
Added: (NovoRapid FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Erenumab 140mg/1ml solution for injection pre-filled disposable devices; Erenumab 70mg/1ml solution for injection pre-filled disposable devices; Sarilumab 150mg/1.14ml solution for injection pre-filled syringes; Sarilumab 200mg/1.14ml solution for injection pre-filled syringes; Sarilumab 150mg/1.14ml solution for injection pre-filled disposable devices; Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices; Mitomycin 40mg powder and solvent for intravesical solution vials; Imatinib 100mg tablets; Imatinib 400mg tablets.Removed: Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free.Changed: Simulect 10mg powder and solvent forsolution for injection vials (1 vial) to Basiliximab 10mg powder and solvent forsolution for injection vials; Simulect 20mg powder and solvent for solution for injection vials to Basiliximab 20mg powder and solvent for solution for injection vials.
Added: Conestat alfa 2,100 unit powder and solvent for solution for injection vials.
Added the following 4 medicines: Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials, Salbutamol 1mg/1ml nebuliser liquid unit dose vials, Salbutamol 2mg/1ml nebuliser liquid unit dose vials, Tivozanib 1340mg capsules and Tivozanib 890mg capsules. Removed the following medicine: Bexarotene 75mg capsules.
Added the following medicine to the list: Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials.Removed the following medicine from the list:Amlodipine/Valsartan 10mg/160mg tablets;Amlodipine/Valsartan 5mg/80mg tablets.
